This chapter discusses future of thrombolytics. History and evolution of fibrinolytic therapy is discussed. Role of thrombolytics for acute myocardial infarction, clinical trials relevant to the development of tenecteplase, assent-3 plus, assent-4 PCI, and future horizons of thrombolytics therapy are described.